Baudax Bio (BXRXQ) Financial Statements
Baudax Bio Financial Overview
Baudax Bio's market cap is currently $44. The company's EPS TTM is $-9.23; its P/E ratio is 0.00; Baudax Bio has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.27M | $ 1.08M | $ 493.00K | $ 0.00 | $ 0.00 |
| Gross Profit | $ -5.74M | $ -1.36M | $ -1.24M | $ 0.00 | $ 0.00 |
| Operating Income | $ -56.81M | $ -19.01M | $ -74.79M | $ -32.52M | $ -73.53M |
| EBITDA | $ -33.58M | $ -49.56M | $ -72.19M | $ -32.08M | $ -64.64M |
| Net Income | $ -58.80M | $ -19.77M | $ -76.10M | $ -32.56M | $ -73.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.26M | $ 15.89M | $ 30.34M | $ 17.74M | $ 0.00 |
| Total Assets | $ 10.03M | $ 53.28M | $ 68.73M | $ 54.21M | $ 35.02M |
| Total Debt | $ 7.12M | $ 8.53M | $ 9.78M | $ 773.00K | $ 0.00 |
| Net Debt | $ 1.86M | $ -7.36M | $ -20.56M | $ -16.97M | $ 0.00 |
| Total Liabilities | $ 34.27M | $ 40.05M | $ 83.53M | $ 70.93M | $ 103.37M |
| Stockholders' Equity | $ -24.24M | $ 13.23M | $ -14.80M | $ -16.72M | $ -68.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -27.81M | $ -49.47M | $ -44.70M | $ -51.53M | $ -63.20M |
| Operating Cash Flow | $ -27.79M | $ -49.27M | $ -44.06M | $ -50.04M | $ -59.75M |
| Investing Cash Flow | $ -20.00K | $ -194.00K | $ -639.00K | $ -1.48M | $ -3.45M |
| Financing Cash Flow | $ 17.18M | $ 35.01M | $ 57.30M | $ 69.27M | $ 63.20M |
Currency in USD